[Avant et Arrière] Ensemble roulement de roue et moyeu pour 2009-2014 Nissan Cube K70-102048 2000-buick-regal Pièces interchangeables/OEM: 1012489 K640361 520-449 KDA-100498
Pay in 4 interest-free payments of $35.56 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 14 - Nov 19
Harbor notes
Description
[Avant et Arrière] Ensemble roulement de roue et moyeu pour 2009 2014 Nissan Cube K70 102048 2000 buick regal Pièces interchangeables OEM: 1012489 K640361 520 449 KDA 100498 Pièces interchangeables OEM: 1012489 K640361 520 449 CA74263 MS20245 GS20245 CMS20245 RK640361 54202 2605437 507 1231 CP1383 TK640361 CK640361 21340001 TQC CK640361 1012488 K640360 520 450 CA74264 MS20244 GS20244 CMS20244 RK640360 44202 2605438 507 1232 CP1384 TK640360 CK640360 21340002 TQC CK640360 1002472 534 543 T3306 TO74035 GES3306 GES3713 MES3306 MES3713 ES3306 ES3713 2692843 401 1525 TES3306 TES3713 JTE683 89340019 TQC ES3306 Numéro de pièce: K7T 100672 Produit: Ensemble roulement de roue et moyeu 2011 Nissan Cube
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
Frequently Asked Questions for [Avant et Arrière] Ensemble roulement de roue et moyeu pour 2009-2014 Nissan Cube K70-102048 2000-buick-regal Pièces interchangeables/OEM: 1012489 K640361 520-449 KDA-100498
What should I check when reading a translated product listing?
Look for consistency between the final selection and the description you reviewed. Make the decision from verified meaning rather than the most favorable interpretation of translated wording.
How can I make a useful comparison table for several products?
Add relevant limitations alongside the positive features. Save the final comparison with the relevant purchase notes.
How can I check whether a purchase involves ongoing commitments?
Do not infer indefinite access or support from an unspecified term. Do not treat a trial label as a complete explanation of what follows it.